EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,059,539 | +2.3% | 67,187 | +26.1% | 0.03% | 0.0% |
| Q2 2023 | $1,035,705 | +140.8% | 53,277 | +251.5% | 0.03% | +125.0% |
| Q1 2023 | $430,032 | -6.5% | 15,158 | +37.5% | 0.01% | -71.4% |
| Q1 2021 | $460,000 | -42.9% | 11,027 | -41.8% | 0.04% | -19.2% |
| Q3 2020 | $805,000 | -11.3% | 18,954 | -4.0% | 0.05% | -21.2% |
| Q1 2020 | $908,000 | +105.4% | 19,739 | +125.5% | 0.07% | +112.9% |
| Q1 2019 | $442,000 | -48.7% | 8,753 | -59.1% | 0.03% | -42.6% |
| Q4 2018 | $862,000 | +254.7% | 21,405 | +510.2% | 0.05% | +200.0% |
| Q3 2018 | $243,000 | – | 3,508 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |